Identification of subtypes in subjects with mild-to-moderate airflow limitation and its clinical and socioeconomic implications

References

• AdeloyeDChuaSLeeCGlobal and regional estimates of COPD prevalence: Systematic review and meta-analysisJ Glob Health20155202041526755942
   PubMed Web of Science ®Google Scholar
• JamesPAOparilSCarterBL2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)JAMA2014311550752024352797
   PubMed Web of Science ®Google Scholar
• American DiabetesA4. Prevention or delay of type 2 diabetesDiabetes Care201639Suppl 1S36S3826696678
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Diseaseglobal Strategy for the Diagnosis, Management and Prevention of COPD2017 Available from: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/Accessed January 20, 2017
   Google Scholar
• KrahnMChapmanKREconomic issues in the use of office spirometry for lung health assessmentCan Respir J200310632032614530824
   PubMedGoogle Scholar
• QaseemAWiltTJWeinbergerSEDiagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory SocietyAnn Intern Med2011155317919121810710
   PubMed Web of Science ®Google Scholar
• Force USPSTSiuALBibbins-DomingoKScreening for chronic obstructive pulmonary disease: US Preventive Services Task Force Recommendation StatementJAMA2016315131372137727046365
   PubMed Web of Science ®Google Scholar
• Guirguis-BlakeJMSengerCAWebberEMMularskiRAWhitlockEPScreening for chronic obstructive pulmonary disease: evidence report and systematic review for the US Preventive Services Task ForceJAMA2016315131378139327046366
   PubMed Web of Science ®Google Scholar
• VestboJRennardSChronic obstructive pulmonary disease biomarker(s) for disease activity needed–urgentlyAm J Respir Crit Care Med2010182786386420884938
   PubMed Web of Science ®Google Scholar
• FanerRTal-SingerRRileyJHLessons from ECLIPSE: a review of COPD biomarkersThorax201469766667224310110
   PubMed Web of Science ®Google Scholar
• SinDDVestboJBiomarkers in chronic obstructive pulmonary diseaseProc Am Thorac Soc20096654354519741266
   PubMedGoogle Scholar
• CelliBRCoteCGMarinJMThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med2004350101005101214999112
   PubMed Web of Science ®Google Scholar
• LeeJHChoMHMcDonaldMLPhenotypic and genetic heterogeneity among subjects with mild airflow obstruction in COPDGeneRespir Med2014108101469148025154699
   PubMed Web of Science ®Google Scholar
• ReganEALynchDACurran-EverettDClinical and radio-logic disease in smokers with normal spirometryJAMA Intern Med201517591539154926098755
   PubMed Web of Science ®Google Scholar
• PauwelsRARabeKFBurden and clinical features of chronic obstructive pulmonary disease (COPD)Lancet2004364943461362015313363
   PubMed Web of Science ®Google Scholar
• JanssonSABackmanHStenlingALindbergARonmarkELundbackBHealth economic costs of COPD in Sweden by disease severity–has it changed during a ten years period?Respir Med2013107121931193823910072
   PubMed Web of Science ®Google Scholar
• ScholsAMSlangenJVolovicsLWoutersEFWeight loss is a reversible factor in the prognosis of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981576 Pt 1179117979620907
   PubMed Web of Science ®Google Scholar
• VestboJPrescottEAlmdalTBody mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart StudyAm J Respir Crit Care Med20061731798316368793
   PubMed Web of Science ®Google Scholar
• BhavaniSTsaiCLPerusichSClinical and immunological factors in emphysema progression. Five-year prospective longitudinal exacerbation study of chronic obstructive pulmonary disease (LES-COPD)Am J Respir Crit Care Med2015192101171117826241705
   PubMed Web of Science ®Google Scholar
• BurneyPGChinnSBrittonJRTattersfieldAEPapacostaAOWhat symptoms predict the bronchial response to histamine? Evaluation in a community survey of the bronchial symptoms questionnaire (1984) of the International Union Against Tuberculosis and Lung DiseaseInt J Epidemiol19891811651732656559
   PubMed Web of Science ®Google Scholar
• ArifAADelclosGLLeeESTortoleroSRWhiteheadLWPrevalence and risk factors of asthma and wheezing among US adults: an analysis of the NHANES III dataEur Respir J200321582783312765429
   PubMed Web of Science ®Google Scholar
• KweonSKimYJangMJData resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES)Int J Epidemiol2014431697724585853
   PubMed Web of Science ®Google Scholar
• PellegrinoRViegiGBrusascoVInterpretative strategies for lung function testsEur Respir J200526594896816264058
   PubMed Web of Science ®Google Scholar
• HwangYIKimCHKangHRComparison of the prevalence of chronic obstructive pulmonary disease diagnosed by lower limit of normal and fixed ratio criteriaJ Korean Med Sci200924462162619654942
   PubMed Web of Science ®Google Scholar
• BurneyPGLuczynskaCChinnSJarvisDThe European Community Respiratory Health SurveyEur Respir J1994759549608050554
   PubMed Web of Science ®Google Scholar
• RabinRde CharroFEQ-5D: a measure of health status from the EuroQol GroupAnn Med200133533734311491192
   PubMed Web of Science ®Google Scholar
• SniderGLChronic obstructive pulmonary disease: risk factors, pathophysiology and pathogenesisAnnu Rev Med1989404114292658758
   PubMed Web of Science ®Google Scholar
• PostmaDSBushAvan den BergeMRisk factors and early origins of chronic obstructive pulmonary diseaseLancet2015385997189990925123778
   PubMed Web of Science ®Google Scholar
• AffesZRekikSBen SaadHDefining obstructive ventilatory defect in 2015Libyan J Med20151028946
   Web of Science ®Google Scholar
• BuffelsJDegryseJHeyrmanJDecramerMStudyDOffice spirometry significantly improves early detection of COPD in general practice: the DIDASCO StudyChest200412541394139915078751
   PubMed Web of Science ®Google Scholar
• AverameGBonaviaMFerriPOffice spirometry can improve the diagnosis of obstructive airway disease in primary care settingRespir Med2009103686687219200705
   PubMed Web of Science ®Google Scholar
• XuanWPeatJKToelleBGMarksGBBerryGWoolcockAJLung function growth and its relation to airway hyperresponsiveness and recent wheeze. Results from a longitudinal population studyAm J Respir Crit Care Med200016161820182410852751
   PubMed Web of Science ®Google Scholar